Patent Assignment
Reel/Frame 053440/0178
Security Interest
Recorded: 2020-08-10
Pages: 12
Assignor
VACCINEX, INC.
Executed: 2020-08-03
Assignee
3I, L.P.
140 BROADWAY, 38TH FLOOR, NEW YORK, NEW YORK, 10005
Covered Properties
(44)
Targeted cd1d molecules
Anti-CD20 Antibodies and Methods of Use
Human Anti-CD100 Antibodies
Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules
Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
Polynucleotides Encoding Anti-CD100 Antibodies or Antigen-binding Fragments Thereof
Anti-Vegf Antibodies and Uses Thereof
Use of the Combination of Semaphorin-4D Inhibitory Molecules and Vegf Inhibitory Molecules to Inhibit Angiogenesis
Anti-CD100 Antibodies and Methods of Using the Same
Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
Anti-CXCL13 Antibodies and Methods of Using the Same
Anti-SEMA4D Antibodies and Epitopes
Use of Semaphorin-4D Binding Molecules to Promote Neurogenesis Following Stroke
Fusion Proteins to Facilitate Selection of Cells Infected with Specific Immunoglobulin Gene Recombinant Vaccinia Virus
Osteogenesis Promoter
Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases
Methods for the Treatment of B Cell-Mediated Inflammatory Diseases
Use of Semaphorin-4D Binding Molecules for Treatment of Atherosclerosis
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
Methods for Increasing Immunoglobulin a Levels
Use of Antibodies or Antigen-Binding Fragments Thereof that Specifically Bind Semaphorin-4D to Increase Tumor Infiltrating Leukocyte Frequency
Method for Selecting Polynucleotides Encoding Antigen-Specific Immunoglobulin Subunits
Method of Treating Multiple Sclerosis Using Anti-CD20 Antibodies
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
Anti-CD100 Antibodies and Methods for Using the Same
Method for Selecting Polynucleotides Encoding Antigen-Specific Immunoglobulin Subunit
Use of Anti-Semaphorin-4D Antibodies in Combination with an Immune Modulating Therapy to Inhibit Tumor Growth and Metastases
Polynucleotides Encoding Anti-CXCL13 Antibodies
Integral Membrane Protein Display on Poxvirus Extracellular Enveloped Virions
Methods for Producing Polynucleotide Libraries in Vaccinia Virus/Eukaryotic Cells
Integral Membrane Protein Display on Poxvirus Extracellular Enveloped Virions
Use of Semaphorin-4D Inhibitory Molecules with an Immune Modulating Therapy to Inhibit Tumor Growth and Metastases
Use of Semaphorin-4D Binding Molecules for Modulation of Blood Brain Barrier Permeability
Use of Semaphorin-4D Binding Molecules for Treating Neurodegenerative Disorders
Early Detection of Glial Cell Activation in Neurodegenerative or Neuroinflammatory Diseases
Application:
16/488,123 →
Publication:
US 2019/0383836
Treatment of Cancer with a Semaphorin-4D Antibody in Combination with an Epigenetic Modulating Agent
Human Anti-Semaphorin 4D Antibody
Integral Membrane Protien Display on Poxvirus Extracellular Enveloped Virions
Semaphorin-4D Antagonists for Use in Cancer Therapy
Application:
16/832,170 →
Publication:
US 2020/0317788
Methods for Producing Polynucleotide Libraries in Vaccinia Virus/Eukaryotic Cells
Application:
16/860,217 →
Publication:
US 2020/0299683
Combination Therapy with Semaphorin-4D Blockade (SEMA4D) and DC1 Therapy
Combination Therapy with Semaphorin-4D Blockade (SEMA4D) and DC1 Therapy
Application:
62/865,027 →
Combined Inhibition of Semaphorin-4D and Tgf-Beta and Compositions Therefor
Application:
62/881,751 →
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 6, 2006
From: ROBERT, BRUNO; DONDA, ALENA; CESSON, VALERIE; MACH, JEAN-PIERRE
To: VACCINEX, INC.
Reel/Frame 018360/0977 →
Assignment of Assignor's Interest
Apr 10, 2009
From: SMITH, ERNEST S.; FISHER, TERRENCE L., JR.; ZAUDERER, MAURICE
To: VACCINEX, INC.
Reel/Frame 022532/0109 →
Assignment of Assignor's Interest
Apr 21, 2009
From: SMITH, ERNEST S.; FISHER, TERRENCE L., JR.
To: VACCINEX, INC.
Reel/Frame 022573/0324 →
Assignment of Assignor's Interest
Jul 17, 2009
From: UNIVERSITY OF LAUSANNE
To: VACCINEX, INC.
Reel/Frame 022969/0936 →
Assignment of Assignor's Interest
Jul 17, 2009
From: DONDA, ALENA; MACH, JEAN-PIERRE; STIRNEMANN, KATHRIN
To: UNIVERSITY OF LAUSANNE
Reel/Frame 022970/0045 →
Assignment of Assignor's Interest
Jun 9, 2010
From: SMITH, ERNEST S.; FISHER, TERRENCE LEE
To: VACCINEX, INC.
Reel/Frame 024511/0488 →
Assignment of Assignor's Interest
Jun 14, 2012
From: SMITH, ERNEST S.; FISHER, TERRENCE LEE
To: VACCINEX, INC.
Reel/Frame 028378/0159 →
Assignment of Assignor's Interest
Apr 18, 2013
From: SMITH, ERNEST S.; FISHER, TERRENCE LEE
To: VACCINEX, INC.
Reel/Frame 030246/0617 →
Assignment of Assignor's Interest
Jun 5, 2013
From: SMITH, ERNEST S.; PANDINA, TRACY; CROY, LESLIE A.; PARIS, MARK
To: VACCINEX, INC.
Reel/Frame 030552/0001 →
Assignment of Assignor's Interest
Jun 5, 2013
From: SMITH, ERNEST S.; ZAUDERER, MAURICE
To: VACCINEX, INC.
Reel/Frame 030551/0978 →
Assignment of Assignor's Interest
Jun 5, 2013
From: FISHER, TERRENCE LEE; SMITH, ERNEST S.; ZAUDERER, MAURICE
To: VACCINEX, INC.
Reel/Frame 030552/0027 →
Assignment of Assignor's Interest
Jun 11, 2013
From: BASILE, JOHN R.; EVANS, ELIZABETH E.; SMITH, ERNEST S.
To: VACCINEX, INC.
Reel/Frame 030589/0583 →
Assignment of Assignor's Interest
Jun 12, 2014
From: TAKAYANAGI, HIROSHI; NEGISHI, TAKAKO
To: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
Reel/Frame 033089/0943 →
Assignment of Assignor's Interest
Aug 1, 2014
From: EVANS, ELIZABETH E.; SMITH, ERNEST S.; ZAUDERER, MAURICE
To: VACCINEX, INC.
Reel/Frame 033444/0404 →
Assignment of Assignor's Interest
Feb 10, 2015
From: SMITH, ERNEST S.; ZAUDERER, MAURICE
To: VACCINEX, INC.
Reel/Frame 034926/0951 →
Assignment of Assignor's Interest
Apr 1, 2016
From: KLIMATCHEVA, EKATERINA; PARIS, MARK; SMITH, ERNEST S.
To: VACCINEX, INC.
Reel/Frame 038167/0147 →
Assignment of Assignor's Interest
Aug 6, 2018
From: CROY, LESLIE A; PARIS, MARK J; SMITH, ERNEST S
To: VACCINEX, INC.
Reel/Frame 046566/0405 →
Release of Security Interest
Jan 9, 2023
From: VACCINEX, INC.
To: 3I, L.P.
Reel/Frame 062308/0405 →